Cardiovascular–kidney–metabolic syndrome (CKM syndrome) is a multisystem disorder of the metabolic, renal and cardiovascular systems.[1] The interactions between metabolic risk factors, such as type 2 diabetes and obesity, with chronic kidney disease and cardiovascular disorders lead to an increased mortality risk and significant impact on morbidity.[1]
| Cardiovascular–kidney–metabolic syndrome | |
|---|---|
| Other names | CKM syndrome |
| Specialty | |
| Prevention | Life-style changes |
See also
editReferences
edit- ^ a b Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, Despres JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekavich CL, Lewis EF, Lo KB, Ozkan B, Palaniappan LP, Patel SS, Pencina MJ, Powell-Wiley TM, Sperling LS, Virani SS, Wright JT, Rajgopal Singh R, Elkind MS (9 October 2023). "Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association". Circulation. 148 (20): 1606–1635. doi:10.1161/CIR.0000000000001184. ISSN 0009-7322. PMID 37807924. S2CID 263773961.
 | This article about an endocrine, nutritional, or metabolic disease is a stub. You can help Wikipedia by expanding it. |